Profile
| Metric | Value |
|---|---|
| Full Name | LeMaitre Vascular, Inc. |
| Ticker | NASDAQ: LMAT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | lemaitre.com |
| Employees | 651 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $86.51 | |
| Price, 1D Change | +1.23% | |
| Market Cap | $2B | |
| TTM Dividend Yield | 0.92% | |
| PE Ratio | 37.23 | |
| Beta | 0.67 | |
| Revenue | $220M | |
| Revenue, 1Y Change | +13.63% | |
| EPS | $1.93 | |
| EPS, 1Y Change | +44.00% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.20 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $1.93 | |
| EPS Estimate | $2.42 | |
| EPS Est. Change | +25.07% | |
| Revenue | $219.86M | |
| Revenue Estimate | $248.26M | |
| Revenue Est. Change | +12.92% | |
| Current Price | $86.51 | |
| Price Target | - | $108.00 |
| Price Tgt. Change | - | +24.84% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.33 | $1.34 | +0.95% | |
| $1.94 | $1.93 | -0.40% | |
| $2.42 | N/A | +25.07% | |
| $2.59 | N/A | +33.86% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $193.62M | $193.48M | -0.07% | |
| $220.12M | $219.86M | -0.12% | |
| $248.26M | N/A | +12.92% | |
| $270.77M | N/A | +23.15% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -11.51% | |
| Price, 3Y | +87.54% | |
| Market Cap, 1Y | -10.97% | |
| Market Cap, 3Y | +92.62% | |
| Revenue, 1Y | +13.63% | |
| Revenue, 3Y | +42.38% | |
| EPS, 1Y | +44.00% | |
| EPS, 3Y | +54.29% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $86.51 | |
| SMA 200 | $86.21 | |
| SMA 200 vs Price | -0.35% | |
| SMA 50 | $84.83 | |
| SMA 50 vs Price | -1.95% | |
| Beta | 0.67 | |
| ATR | $2.56 | |
| 14-Day RSI | 55.89 | |
| 10-Day Volatility | 26.65% | |
| 1-Year Volatility | 32.91% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.20 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 0.74% | |
| Total Dividend | $0.64 | |
| Dividends Paid | $14.38M | |
| Payout Ratio | 32.65% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $219.86M | |
| EPS | $1.93 | |
| Gross Profit | $145.12M | |
| Gross Margin | 66.00% | |
| Operating Profit | $52.26M | |
| Operating Margin | 23.83% | |
| Net Income | $44.04M | |
| Net Margin | 20.03% | |
| EBITDA | $66.75M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.55 | |
| Current Ratio | 12.85 | |
| Quick Ratio | 11.02 | |
| - | ||
| F-Score | 6 | |
| Altman Z-Score | 7.39 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 37.23 | |
| PS Ratio | 8.15 | |
| PB Ratio | 5.18 | |
| EV/EBITDA | 24.99 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $337.29M | |
| Cash & Equivalents | $299.72M | |
| Total Assets | $551.82M | |
| Current Assets | $393.21M | |
| Total Liabilities | $214.53M | |
| Current Liabilities | $30.61M | |
| Total Debt | $185.69M | |
| Short Term Debt | $2.68M | |
| Accounts Payable | $1.76M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $175.83M | |
| Operating Expenses | $92.73M | |
| Cost Of Goods Sold | $74.75M | |
| SG&A | $0.00 | |
| D&A | $9.67M | |
| Interest Expense | $0.00 | |
| Income Tax | $12.84M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $44.12M | |
| CFI | -$200.12M | |
| CFF | $158.10M | |
| Capex | $6.96M | |
| Free Cash Flow | $37.16M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wells Fargo | → | |
| Barrington Research | → | |
| Barrington Research | → | |
| Cantor Fitzgerald | → | |
| Barrington Research | → | |
| Barrington Research | → | |
| Lake Street | → | |
| Citizens Capital Markets | → | |
| Barrington Research | → | |
| Wells Fargo |
Analyst sentiment
Institutional ownership
Screeners with LMAT
Data Sources & References
- LMAT Official Website www.lemaitre.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1158895/000119312525270981/0001193125-25-270981-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1158895/000143774925005637/0001437749-25-005637-index.htm
- LMAT Profile on Yahoo Finance finance.yahoo.com/quote/LMAT
- LMAT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lmat
FAQ
What is the ticker symbol for LeMaitre Vascular, Inc.?
The ticker symbol for LeMaitre Vascular, Inc. is NASDAQ:LMAT
Does LeMaitre Vascular, Inc. pay dividends?
Yes, LeMaitre Vascular, Inc. pays dividends. The last payment was $0.20, with an ex-dividend date on November 20, 2025
What sector is LeMaitre Vascular, Inc. in?
LeMaitre Vascular, Inc. is in the Healthcare sector
What industry is LeMaitre Vascular, Inc. in?
LeMaitre Vascular, Inc. is in the Medical Instruments & Supplies industry
What country is LeMaitre Vascular, Inc. based in?
LeMaitre Vascular, Inc. is headquartered in United States
When did LeMaitre Vascular, Inc. go public?
LeMaitre Vascular, Inc. initial public offering (IPO) was on October 19, 2006
Is LeMaitre Vascular, Inc. in the S&P 500?
No, LeMaitre Vascular, Inc. is not included in the S&P 500 index
Is LeMaitre Vascular, Inc. in the NASDAQ 100?
No, LeMaitre Vascular, Inc. is not included in the NASDAQ 100 index
Is LeMaitre Vascular, Inc. in the Dow Jones?
No, LeMaitre Vascular, Inc. is not included in the Dow Jones index
When was LeMaitre Vascular, Inc. last earnings report?
LeMaitre Vascular, Inc.'s most recent earnings report was on November 6, 2025
When does LeMaitre Vascular, Inc. report earnings?
The next expected earnings date for LeMaitre Vascular, Inc. is March 2, 2026
